Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 20 studies | 28% ± 14% | |
non-classical monocyte | 19 studies | 32% ± 16% | |
monocyte | 11 studies | 22% ± 6% | |
macrophage | 7 studies | 25% ± 7% | |
endothelial cell | 5 studies | 23% ± 5% | |
myeloid cell | 5 studies | 27% ± 10% | |
epithelial cell | 5 studies | 32% ± 9% | |
basal cell | 5 studies | 24% ± 5% | |
hepatocyte | 5 studies | 46% ± 15% | |
astrocyte | 5 studies | 29% ± 10% | |
ciliated cell | 4 studies | 21% ± 3% | |
adipocyte | 4 studies | 21% ± 5% | |
GABAergic neuron | 4 studies | 23% ± 7% | |
oligodendrocyte precursor cell | 4 studies | 29% ± 10% | |
neutrophil | 4 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 6871.57 | 245 / 245 | 100% | 26.02 | 502 / 502 |
esophagus | 100% | 8817.56 | 1444 / 1445 | 100% | 35.16 | 183 / 183 |
liver | 100% | 17354.28 | 226 / 226 | 100% | 45.36 | 405 / 406 |
thymus | 100% | 8762.78 | 652 / 653 | 100% | 33.88 | 604 / 605 |
breast | 100% | 9405.17 | 459 / 459 | 100% | 32.39 | 1114 / 1118 |
intestine | 100% | 7148.23 | 965 / 966 | 99% | 21.61 | 522 / 527 |
uterus | 100% | 7326.98 | 170 / 170 | 99% | 35.65 | 454 / 459 |
skin | 100% | 14218.65 | 1809 / 1809 | 98% | 20.99 | 464 / 472 |
bladder | 100% | 9106.90 | 21 / 21 | 98% | 38.07 | 495 / 504 |
lung | 99% | 6560.54 | 572 / 578 | 99% | 27.35 | 1142 / 1155 |
stomach | 98% | 5865.68 | 353 / 359 | 99% | 21.79 | 284 / 286 |
kidney | 99% | 5682.73 | 88 / 89 | 96% | 20.73 | 862 / 901 |
adrenal gland | 100% | 10153.01 | 258 / 258 | 94% | 19.12 | 217 / 230 |
pancreas | 93% | 3857.80 | 304 / 328 | 100% | 24.15 | 178 / 178 |
brain | 91% | 4426.28 | 2412 / 2642 | 100% | 30.51 | 702 / 705 |
ovary | 100% | 8160.79 | 180 / 180 | 91% | 13.41 | 390 / 430 |
eye | 0% | 0 | 0 / 0 | 100% | 36.36 | 80 / 80 |
muscle | 100% | 20121.39 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 10042.92 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 46.29 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 44.69 | 1 / 1 |
adipose | 100% | 10982.89 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6338.17 | 1330 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 13401.51 | 921 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 4789.73 | 821 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 10.15 | 24 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035357 | Biological process | peroxisome proliferator activated receptor signaling pathway |
GO_0002157 | Biological process | positive regulation of thyroid hormone receptor signaling pathway |
GO_0070564 | Biological process | positive regulation of vitamin D receptor signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030154 | Biological process | cell differentiation |
GO_0010875 | Biological process | positive regulation of cholesterol efflux |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0043401 | Biological process | steroid hormone receptor signaling pathway |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_0032526 | Biological process | response to retinoic acid |
GO_0032411 | Biological process | positive regulation of transporter activity |
GO_0048856 | Biological process | anatomical structure development |
GO_0048384 | Biological process | retinoic acid receptor signaling pathway |
GO_0030501 | Biological process | positive regulation of bone mineralization |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0043235 | Cellular component | receptor complex |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0050693 | Molecular function | LBD domain binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003707 | Molecular function | nuclear steroid receptor activity |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0042277 | Molecular function | peptide binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0001221 | Molecular function | transcription coregulator binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0070644 | Molecular function | vitamin D response element binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0050692 | Molecular function | DNA binding domain binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0001972 | Molecular function | retinoic acid binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0044323 | Molecular function | retinoic acid-responsive element binding |
GO_0042809 | Molecular function | nuclear vitamin D receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RXRA |
Protein name | Retinoic acid receptor RXR (Nuclear receptor subfamily 2 group B member) Retinoid X receptor alpha Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) |
Synonyms | NR2B1 |
Description | FUNCTION: Receptor for retinoic acid that acts as a transcription factor . Forms homo- or heterodimers with retinoic acid receptors (RARs) and binds to target response elements in response to their ligands, all-trans or 9-cis retinoic acid, to regulate gene expression in various biological processes . The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5 to regulate transcription . The high affinity ligand for retinoid X receptors (RXRs) is 9-cis retinoic acid . In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone deacetylation, chromatin condensation and transcriptional suppression . On ligand binding, the corepressors dissociate from the receptors and coactivators are recruited leading to transcriptional activation . Serves as a common heterodimeric partner for a number of nuclear receptors, such as RARA, RARB and PPARA . The RXRA/RARB heterodimer can act as a transcriptional repressor or transcriptional activator, depending on the RARE DNA element context . The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes . Together with RARA, positively regulates microRNA-10a expression, thereby inhibiting the GATA6/VCAM1 signaling response to pulsatile shear stress in vascular endothelial cells . Acts as an enhancer of RARA binding to RARE DNA element . May facilitate the nuclear import of heterodimerization partners such as VDR and NR4A1 . Promotes myelin debris phagocytosis and remyelination by macrophages . Plays a role in the attenuation of the innate immune system in response to viral infections, possibly by negatively regulating the transcription of antiviral genes such as type I IFN genes . Involved in the regulation of calcium signaling by repressing ITPR2 gene expression, thereby controlling cellular senescence . . FUNCTION: Receptor for retinoic acid that acts as a transcription factor. Forms homo- or heterodimers with retinoic acid receptors (rars) and binds to target response elements in response to their ligands, all-trans or 9-cis retinoic acid, to regulate gene expression in various biological processes. . FUNCTION: Receptor for retinoic acid that acts as a transcription factor. Forms homo- or heterodimers with retinoic acid receptors (rars) and binds to target response elements in response to their ligands, all-trans or 9-cis retinoic acid, to regulate gene expression in various biological processes. . |
Accessions | ENST00000481739.2 [P19793-1] P19793 A0A3B3IS44 ENST00000649020.1 Q6P3U7 ENST00000672570.1 A0A5F9ZHH6 |